Vancouver, BC
Canada
British Columbia Centre for Disease Control
SARS-CoV-2, COVID-19, Omicron, Delta, Variant of concern, severity, hospitalization, ICU admission, length of stay, Population health
population-based study, HCV infection, extrahepatic manifestations, mortality, direct-acting antivirals, inverse probability of treatment weighting
ethnic disparities, extrahepatic manifestations, population health, health administrative data, HCV infection
HBV treatment, liver-related mortality, all-cause mortality, cirrhosis, British Columbia
hepatitis C, cost-effectiveness analysis, Markov model